Debt-to-equity in % of PAVmed Inc. from Q3 2017 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
PAVmed Inc. quarterly Debt-to-equity history and change rate from Q3 2017 to Q3 2025.
  • PAVmed Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 66 %.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

PAVmed Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 66 +172 30 Sep 2025
Q2 2025 135 +232 30 Jun 2025
Q1 2025 -406 -291 -2.5% 31 Mar 2025
Q4 2024 -128 +20 +13.3% 31 Dec 2024
Q3 2024 -105 +91 +46.4% 30 Sep 2024
Q2 2024 -96 +265 +73.3% 30 Jun 2024
Q1 2024 -115 +22,359 +99.5% 31 Mar 2024
Q4 2023 -148 -368 -1.7% 31 Dec 2023
Q3 2023 -197 -278 -3.4% 30 Sep 2023
Q2 2023 -360 -407 -8.8% 30 Jun 2023
Q1 2023 -22,473 -22,495 -1,036.5% 31 Mar 2023
Q4 2022 219 +207 +16.4% 31 Dec 2022
Q3 2022 80 +53 +1.9% 30 Sep 2022
Q2 2022 46 -20 -29.9% 30 Jun 2022
Q1 2022 21 -231 -91.4% 31 Mar 2022
Q4 2021 12 +263 31 Dec 2021
Q3 2021 28 +226 30 Sep 2021
Q2 2021 65 +274 30 Jun 2021
Q1 2021 252 +495 31 Mar 2021
Q4 2020 -250 +46 +15.5% 31 Dec 2020
Q3 2020 -197 +131 +39.8% 30 Sep 2020
Q2 2020 -208 +426 +67.2% 30 Jun 2020
Q1 2020 -242 -1,509 -1.2% 31 Mar 2020
Q4 2019 -296 -603 -2% 31 Dec 2019
Q3 2019 -328 -571 -2.4% 30 Sep 2019
Q2 2019 -634 +504 +44.3% 30 Jun 2019
Q1 2019 1,266 +1,432 31 Mar 2019
Q4 2018 305 +440 31 Dec 2018
Q3 2018 242 +377 30 Sep 2018
Q2 2018 -1,138 30 Jun 2018
Q1 2018 -165 31 Mar 2018
Q4 2017 -134 31 Dec 2017
Q3 2017 -134 30 Sep 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.